These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35296660)

  • 1. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis.
    Wu M; Zhang X; Zhang W; Chiou YS; Qian W; Liu X; Zhang M; Yan H; Li S; Li T; Han X; Qian P; Liu S; Pan Y; Lobie PE; Zhu T
    Nat Commun; 2022 Mar; 13(1):1371. PubMed ID: 35296660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
    Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
    Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells.
    Wu M; Zhang X; Zhang W; Yan L; Liu X; Zhang M; Pan Y; Lobie PE; Han X; Zhu T
    Cell Commun Signal; 2023 Mar; 21(1):59. PubMed ID: 36915147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis.
    Yang Y; Lu Y; Zhang C; Guo Q; Zhang W; Wang T; Xia Z; Liu J; Cheng X; Xi T; Jiang F; Zheng L
    Cell Mol Life Sci; 2022 Jun; 79(7):360. PubMed ID: 35690642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A "Ferroptosis-Amplifier" Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy.
    Zhu Y; Deng X; Dai Z; Liu Q; Kuang Y; Liu T; Chen H
    Nano Lett; 2024 Jul; 24(26):8179-8188. PubMed ID: 38885447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.
    Wang X; Chen Y; Wang X; Tian H; Wang Y; Jin J; Shan Z; Liu Y; Cai Z; Tong X; Luan Y; Tan X; Luan B; Ge X; Ji H; Jiang X; Wang P
    Cancer Res; 2021 Oct; 81(20):5217-5229. PubMed ID: 34385181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.
    Luo M; Shang L; Brooks MD; Jiagge E; Zhu Y; Buschhaus JM; Conley S; Fath MA; Davis A; Gheordunescu E; Wang Y; Harouaka R; Lozier A; Triner D; McDermott S; Merajver SD; Luker GD; Spitz DR; Wicha MS
    Cell Metab; 2018 Jul; 28(1):69-86.e6. PubMed ID: 29972798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal Cancer Stem-like Cells Resist Ferroptosis-Induced Cell Death by Active Hsp27-GPX4 Pathway.
    Liu CC; Li HH; Lin JH; Chiang MC; Hsu TW; Li AF; Yen DH; Hsu HS; Hung SC
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.
    Yadav P; Sharma P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
    Cancer Lett; 2021 Dec; 522():211-224. PubMed ID: 34571083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
    Lin X; Chen W; Wei F; Xie X
    Mol Ther; 2021 Jan; 29(1):244-262. PubMed ID: 32950105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
    Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
    Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoC impacts the metastatic potential and abundance of breast cancer stem cells.
    Rosenthal DT; Zhang J; Bao L; Zhu L; Wu Z; Toy K; Kleer CG; Merajver SD
    PLoS One; 2012; 7(7):e40979. PubMed ID: 22911725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.